In Conversation Dan Bach Kristensen, Principal Scientist, Symphogen

In Conversation With Caroline Barelle, CEO and Co-founder, Elasmogen

At 2021’s Biologics Europe: Online, we sat down with an advisory group of leading industry experts to hear their thoughts on the state of the Biologic drug industry and the potential of Biotherapeutic manufacturing. Biologics engineering is a rapidly evolving field, and 2022 looks to be a year of exciting technological and strategy breakthroughs.

In Conversation With David Brayden, Professor of Advanced Drug Delivery, University College Dublin

2020 and 2021 has been dominated by headlines about the COVID inoculation programme and its tremendous success. But what’s next for the vaccine?

In Conversation With Volker Derdau, Section Head, Isotope Chemistry, Sanofi

The first Biologics EU Series to be held virtually, we look back on some of the event’s highlights and discuss some of the key market trends facing Biologics today.

Presented by Giorgio Marini, Life Science Technical Specialist, CEM Corporation

Featuring presentations from: Dr. Christian Bartling, Post-Doctoral Researcher (Strømgaard Group), University of Copenhagen | Dr. Céline Douat, Scientific Coworker (Huc Group), LMU Munich | Dr. Colin Dunsmore, Team Leader, Almac Sciences | Dr. Robert Zitterbart, Co-founder & Head of R&D, Belyntic GmbH | Dr. Lukasz Frankiewicz, Senior Product Specialist (EMEA), Gyros Protein Technologies | Moderated by Dr. Andrew Kennedy, Global Product Manager, Peptides Business, Gyros Protein Technologies

We spoke with Xianglin Shi, Principal Scientist at Biogen to find out what key milestones have contributed to this growth. This episode is a fantastic 10 minute insight for you to also hear what challenges face oligonucleotide synthesis and a look to what the future holds for this exciting industry.